Cargando…
Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction
BACKGROUND: Free fatty acids (FFA), oxidized low-density lipoprotein (LDL) and its antibodies, lipid profile markers, which are formed under oxidative stress, play an important role in atherosclerotic disease. Assess the levels of these markers in myocardial infarction patients depending on the exte...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098672/ https://www.ncbi.nlm.nih.gov/pubmed/25008008 http://dx.doi.org/10.1186/1476-511X-13-111 |
_version_ | 1782326383170551808 |
---|---|
author | Gruzdeva, Olga Uchasova, Evgenya Dyleva, Yulia Belik, Ekaterina Karetnikova, Victoria Shilov, Alexander Barbarash, Olga |
author_facet | Gruzdeva, Olga Uchasova, Evgenya Dyleva, Yulia Belik, Ekaterina Karetnikova, Victoria Shilov, Alexander Barbarash, Olga |
author_sort | Gruzdeva, Olga |
collection | PubMed |
description | BACKGROUND: Free fatty acids (FFA), oxidized low-density lipoprotein (LDL) and its antibodies, lipid profile markers, which are formed under oxidative stress, play an important role in atherosclerotic disease. Assess the levels of these markers in myocardial infarction patients depending on the extent of coronary artery disease (CAD). METHODS: ST-elevation MI patients with hemodynamically significant stenoses of ≥75% in one, two, three, or more coronary arteries were examined. The patients were divided into three groups according to the severity of coronary lesions. Patients had a ≥75% stenotic lesion in one coronary artery (group 1, n = 135), two coronary arteries (group 2, n = 115), or three or more coronary arteries (group 3, n = 150). The control group comprised healthy subjects (n = 33). RESULTS: FFA levels on day 1 from MI onset were higher in groups 1, 2, and 3 compared with controls. On day 1 from MI onset, oxidized LDL levels were significantly higher in groups 2 and 3 than those in controls (both р = 0.001). Oxidized LDL levels were significantly higher in patients with multivessel CAD compared with those with single-vessel CAD on days 1 and 12. Antibody levels increased with the number of affected arteries. CONCLUSION: High levels FFA, oxidized LDL and its antibody, lipid profile markers, and parameters of the pro/antioxidant systems persist during the subacute phase of MI. |
format | Online Article Text |
id | pubmed-4098672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40986722014-07-16 Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction Gruzdeva, Olga Uchasova, Evgenya Dyleva, Yulia Belik, Ekaterina Karetnikova, Victoria Shilov, Alexander Barbarash, Olga Lipids Health Dis Research BACKGROUND: Free fatty acids (FFA), oxidized low-density lipoprotein (LDL) and its antibodies, lipid profile markers, which are formed under oxidative stress, play an important role in atherosclerotic disease. Assess the levels of these markers in myocardial infarction patients depending on the extent of coronary artery disease (CAD). METHODS: ST-elevation MI patients with hemodynamically significant stenoses of ≥75% in one, two, three, or more coronary arteries were examined. The patients were divided into three groups according to the severity of coronary lesions. Patients had a ≥75% stenotic lesion in one coronary artery (group 1, n = 135), two coronary arteries (group 2, n = 115), or three or more coronary arteries (group 3, n = 150). The control group comprised healthy subjects (n = 33). RESULTS: FFA levels on day 1 from MI onset were higher in groups 1, 2, and 3 compared with controls. On day 1 from MI onset, oxidized LDL levels were significantly higher in groups 2 and 3 than those in controls (both р = 0.001). Oxidized LDL levels were significantly higher in patients with multivessel CAD compared with those with single-vessel CAD on days 1 and 12. Antibody levels increased with the number of affected arteries. CONCLUSION: High levels FFA, oxidized LDL and its antibody, lipid profile markers, and parameters of the pro/antioxidant systems persist during the subacute phase of MI. BioMed Central 2014-07-09 /pmc/articles/PMC4098672/ /pubmed/25008008 http://dx.doi.org/10.1186/1476-511X-13-111 Text en Copyright © 2014 Gruzdeva et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Gruzdeva, Olga Uchasova, Evgenya Dyleva, Yulia Belik, Ekaterina Karetnikova, Victoria Shilov, Alexander Barbarash, Olga Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction |
title | Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction |
title_full | Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction |
title_fullStr | Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction |
title_full_unstemmed | Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction |
title_short | Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction |
title_sort | multivessel coronary artery disease, free fatty acids, oxidized ldl and its antibody in myocardial infarction |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098672/ https://www.ncbi.nlm.nih.gov/pubmed/25008008 http://dx.doi.org/10.1186/1476-511X-13-111 |
work_keys_str_mv | AT gruzdevaolga multivesselcoronaryarterydiseasefreefattyacidsoxidizedldlanditsantibodyinmyocardialinfarction AT uchasovaevgenya multivesselcoronaryarterydiseasefreefattyacidsoxidizedldlanditsantibodyinmyocardialinfarction AT dylevayulia multivesselcoronaryarterydiseasefreefattyacidsoxidizedldlanditsantibodyinmyocardialinfarction AT belikekaterina multivesselcoronaryarterydiseasefreefattyacidsoxidizedldlanditsantibodyinmyocardialinfarction AT karetnikovavictoria multivesselcoronaryarterydiseasefreefattyacidsoxidizedldlanditsantibodyinmyocardialinfarction AT shilovalexander multivesselcoronaryarterydiseasefreefattyacidsoxidizedldlanditsantibodyinmyocardialinfarction AT barbarasholga multivesselcoronaryarterydiseasefreefattyacidsoxidizedldlanditsantibodyinmyocardialinfarction |